Stocks›Halozyme Therapeutics, Inc.☆ ● FreshLatest: Aug 13, 2026
Halozyme Therapeutics, Inc.
HALO✓HealthcareBiotechnologyNASDAQ
● FreshLatest: Aug 13, 2026
$100.09-1.68%
$11.87BMarket cap
27.68xP/E ratio
669.43KVolume (24h)
HealthcareBiotechnologyNASDAQ
Halozyme Therapeutics, Inc. (HALO) Stock Price History
HALO price history from Jul 9, 2021 to Aug 12, 2026. Levels shown in USD; returns are price-only, dividends not reinvested.
Summary
5-year high
$104.78 Aug 11, 2026
5-year low
$29.85 May 9, 2023
52-week range
$61.23 - $104.78
Yearly performance
| Year | Open | Close | High | Low | Return |
|---|
| 2026YTD | $70.31 | $101.79 | $104.78 | $61.33 | +44.77% |
| 2025 | $48.01 | $67.30 | $79.50 | $47.50 | +40.18% |
| 2024 | $37.39 | $47.81 | $65.53 | $33.15 | +27.87% |
| 2023 | $55.13 | $36.96 | $57.00 | $29.85 | -32.96% |
| 2022 | $41.06 | $56.90 | $59.46 | $31.36 | +38.58% |
| 2021 | $45.50 | $40.21 | $46.19 | $31.79 | -11.63% |